日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CD4(+) T cells mediate CAR-T cell-associated immune-related adverse events after BCMA CAR-T cell therapy.

CD4(+) T 细胞介导 BCMA CAR-T 细胞治疗后 CAR-T 细胞相关的免疫相关不良事件。

Ho Matthew, Paruzzo Luca, Noll Julia Han, Stella Federico, Devi Pooja, Ndeupen Sonia, Day Yael A, Chen Gregory M, Cohen Ivan J, Ramirez-Fernandez Angel, Waxman Adam, Kapur Shivani, Chen Fang, Xu Rong, Huff Andrew, Jarocha Danuta, Patel Vrutti, Bochi-Layec Audrey C, Ramasubramanian Ranjani, Liu Shan, Bouvier Riemke, de Souza Vitor B, Patel Heta, Li Ziyu, Carturan Alberto, Michener Peter, Hopkins Caitlin R, Koucky Owen, Minehart Janna, Dimitri Alex, Nabar Neel R, Hasanali Zainul S, Ciccarelli Bryan T, Hung Putzer, Williams Erik, Bartoszek Robert, Lavorando Maya, Mohan Suyash, Gonzalez Vanessa E, Porazzi Patrizia, Bhoj Vijay G, Apostolidis Sokratis A, Vogl Dan T, Porter David L, Scholler John, Diorio Caroline, Roche Aoife M, Everett John K, Bushman Frederic D, Nathanson Katherine L, Stadtmauer Edward A, Susanibar-Adaniya Sandra P, Garfall Alfred L, Ruella Marco, Cohen Adam D, Fraietta Joseph A

Outcomes of relapse after teclistamab therapy in multiple myeloma

多发性骨髓瘤患者接受teclistamab治疗后复发的结局

Yu, Kyle L; Ho, Matthew; Paruzzo, Luca; Stella, Federico; Patel, Heta; Hasanali, Zainul S; Kapur, Shivani; Waxman, Adam J; Vogl, Dan T; Stadtmauer, Edward A; Fraietta, Joseph A; Ruella, Marco; Cohen, Adam D; Garfall, Alfred L; Susanibar-Adaniya, Sandra

Advancing CAR T-cell Therapies with Artificial Intelligence: Opportunities and Challenges

利用人工智能推进CAR-T细胞疗法:机遇与挑战

Luciani, Fabio; Safavi, Arman; Guruprasad, Puneeth; Chen, Linhui; Ruella, Marco

Advances in the understanding and therapeutic manipulation of cancer immune responsiveness: a Society for Immunotherapy of Cancer (SITC) review

癌症免疫反应的理解和治疗调控进展:癌症免疫治疗学会 (SITC) 综述

Cesano, Alessandra; Augustin, Ryan; Barrea, Luigi; Bedognetti, Davide; Bruno, Tullia C; Carturan, Alberto; Hammer, Christian; Ho, Winson S; Kather, Jakob Nikolas; Kirchhoff, Tomas; Lu, Rongze O; McQuade, Jennifer; Najjar, Yana G; Pietrobon, Violena; Ruella, Marco; Shen, Rhine; Soldati, Laura; Spencer, Christine; Betof Warner, Allison; Warren, Sarah; Ziv, Elad; Marincola, Francesco M

SITC vision: Opportunities for deeper understanding of mechanisms of anti-tumor activity, toxicity, and resistance to optimize cancer immunotherapy

SITC愿景:深入了解抗肿瘤活性、毒性和耐药机制,从而优化癌症免疫疗法。

Sullivan, Ryan J; Cillo, Anthony R; Ferris, Robert L; Jenkins, Russell W; Kluger, Harriet M; Kok, Marleen; Lipson, Evan J; Paruzzo, Luca; Redmond, William L; Ruella, Marco; Schalper, Kurt A; Thommen, Daniela S; Tolley, Keith; Yarchoan, Mark; Garnett-Benson, Charlie

CD22-targeted chimeric antigen receptor-modified T cells for children and adults with relapse of B-cell acute lymphoblastic leukemia after CD19-directed immunotherapy

CD22靶向嵌合抗原受体修饰的T细胞用于治疗CD19靶向免疫疗法后复发的B细胞急性淋巴细胞白血病儿童和成人患者

Myers, Regina M; DiNofia, Amanda M; Li, Yimei; Diorio, Caroline; Liu, Hongyan; Wertheim, Gerald; Fraietta, Joseph A; Gonzalez, Vanessa; Plesa, Gabriela; Siegel, Donald L; Iannone, Emma; Shinehouse, Laura; Brogdon, Jennifer L; Taylor, Clare; Jadlowsky, Julie K; Hexner, Elizabeth O; Engels, Boris; Baniewicz, Diane; Callahan, Colleen; Ruella, Marco; Aplenc, Richard; Barz Leahy, Allison; McClory, Susan E; Rheingold, Susan R; Wray, Lisa; June, Carl H; Maude, Shannon L; Frey, Noelle V; Grupp, Stephan A

Association of age, race, and ethnicity with access, response, and toxicities from CAR-T therapy in children and adults with B-cell malignancies: a review

年龄、种族和民族与儿童和成人B细胞恶性肿瘤患者接受CAR-T疗法的机会、疗效和毒性之间的关联:一项综述

Ghilardi, Guido; Hasanali, Zainul S; Susanibar-Adaniya, Sandra P; Winestone, Lena E; Ruella, Marco; Garfall, Alfred L

CD19 CAR T-Cell Therapy in Richter Transformation: A Multicentre Retrospective Analysis by the European Research Initiative on Chronic Lymphocytic Leukaemia

CD19 CAR T 细胞疗法治疗 Richter 转化:欧洲慢性淋巴细胞白血病研究计划的多中心回顾性分析

Beyar-Katz, Ofrat; Benjamini, Ohad; Delgado, Julio; Ruella, Marco; Ram, Ron; Grisariu, Sigal; Visentin, Andrea; Vandenberghe, Elisabeth; Gentile, Massimo; Avigdor, Abraham; Shimoni, Avichai; Shouval, Roni; Marcus, Ronit; Schuster, Stephen J; Ortiz-Maldonado, Valentin; Ghilardi, Guido; Paruzzo, Luca; Zuckerman, Tsila; Tadmor, Tamar; Fineman, Riva; Amit, Odelia; Martinez-Cibrian, Nuria; Gabrielli, Giulia; Avni, Batia; Minga, Eva; Shem-Tov, Noga; Scarfo, Lydia; Yerushalmi, Ronit; Nagler, Arnon; Leiba, Ronit; Danylesko, Ivetta; Stamatopoulos, Kostas; Chatzikonstantinou, Thomas; Ghia, Paolo; Herishanu, Yair

Efficacy and safety of bendamustine for lymphodepletion before lisocabtagene maraleucel

利索卡巴吉内马拉鲁塞治疗前使用苯达莫司汀进行淋巴清除的疗效和安全性

Ghilardi, Guido; Paruzzo, Luca; Patel, Vrutti; Svoboda, Jakub; Chong, Emeline R; Fardella, Eugenio; Chong, Elise A; Gabrielli, Giulia; Nasta, Sunita D; Landsburg, Daniel J; Carter, Jordan; Pajarillo, Raymone; Barta, Stefan K; White, Griffin; Weber, Elizabeth; Napier, Ellen; Porter, David L; Garfall, Alfred L; Schuster, Stephen J; Ruella, Marco

CD5 deletion enhances the antitumor activity of adoptive T cell therapies.

CD5 缺失可增强过继性 T 细胞疗法的抗肿瘤活性

Patel Ruchi P, Ghilardi Guido, Zhang Yunlin, Chiang Yi-Hao, Xie Wei, Guruprasad Puneeth, Kim Ki Hyun, Chun Inkook, Angelos Mathew G, Pajarillo Raymone, Hong Seok Jae, Lee Yong Gu, Shestova Olga, Shaw Carolyn, Cohen Ivan, Gupta Aasha, Vu Trang, Qian Dean, Yang Steven, Nimmagadda Aditya, Snook Adam E, Siciliano Nicholas, Rotolo Antonia, Inamdar Arati, Harris Jaryse, Ugwuanyi Ositadimma, Wang Michael, Carturan Alberto, Paruzzo Luca, Chen Linhui, Ballard Hatcher J, Blanchard Tatiana, Xu Chong, Abdel-Mohsen Mohamed, Gabunia Khatuna, Wysocka Maria, Linette Gerald P, Carreno Beatriz, Barrett David M, Teachey David T, Posey Avery D, Powell Daniel J Jr, Sauter C Tor, Pileri Stefano, Pillai Vinodh, Scholler John, Rook Alain H, Schuster Stephen J, Barta Stefan K, Porazzi Patrizia, Ruella Marco